Virtus LifeSci Biotech Products ETF (BBP)

Assets	$17.84M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	350,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+0.03%

Volume	427
Open	50.43
Previous Close	50.60
Day's Range	51.43 - 51.43
52-Week Low	45.00
52-Week High	63.25
Beta	0.84
Holdings	55
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

27.07% of assets

Name	Symbol	Weight
Tarsus Pharmaceuticals, Inc.	TARS	3.61%
ADMA Biologics, Inc.	ADMA	3.30%
Agios Pharmaceuticals, Inc.	AGIO	2.71%
Lexicon Pharmaceuticals, Inc.	LXRX	2.70%
Sarepta Therapeutics, Inc.	SRPT	2.60%
Moderna, Inc.	MRNA	2.51%
Ascendis Pharma A/S	ASND	2.48%
SpringWorks Therapeutics, Inc.	SWTX	2.46%
Intra-Cellular Therapies, Inc.	ITCI	2.36%
Neurocrine Biosciences, Inc.	NBIX	2.32%